{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:55:39Z","timestamp":1780581339928,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cyto.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:31:52Z","timestamp":1534897912000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis"],"prefix":"10.1016","volume":"111","author":[{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.M.","family":"Novais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.P.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.08.019_b0005","first-page":"22","article-title":"Control of the leishmaniases","author":"World Health Organization","year":"2016","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.cyto.2018.08.019_b0010","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"WHO Leishmaniasis control team. Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40249-017-0375-2","article-title":"Addressing vulnerability, building resilience: community-based adaptation to vector-borne diseases in the context of global change","volume":"6","author":"Bardosh","year":"2017","journal-title":"Infect Dis Poverty."},{"issue":"10","key":"10.1016\/j.cyto.2018.08.019_b0020","doi-asserted-by":"crossref","first-page":"e1006571","DOI":"10.1371\/journal.ppat.1006571","article-title":"Combining epidemiology with basic biology of sand flies, parasites, and hosts to inform leishmaniasis transmission dynamics and control","volume":"13","author":"Courtenay","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0025","doi-asserted-by":"crossref","first-page":"e0006250","DOI":"10.1371\/journal.pntd.0006250","article-title":"Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled\/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease","volume":"12","author":"Lenk","year":"2018","journal-title":"PLoS Negl. Trop Dis."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2018.08.019_b0030","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther Adv Infect Dis."},{"issue":"8","key":"10.1016\/j.cyto.2018.08.019_b0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3389\/fimmu.2017.01779","article-title":"Alternative to chemotherapy-the unmet demand against leishmaniasis","volume":"21","author":"Didwania","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2018.08.019_b0040","doi-asserted-by":"crossref","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"22","author":"Ghorbani","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.cyto.2018.08.019_b0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"Feb; 82","author":"Amit","year":"2017","journal-title":"Mol Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s13071-017-2576-8","article-title":"Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection","volume":"10","author":"Ramos","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.cyto.2018.08.019_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2018.08.019_b0065","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3389\/fimmu.2017.01763","article-title":"Identification of potential MHC class-II-restricted epitopes derived from <i>Leishmania donovani<\/i> antigens by reverse vaccinology and evaluation of their CD4+ T-cell responsiveness against visceral leishmaniasis","volume":"14","author":"Dikhit","year":"2017","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.019_b0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev Soc Bras Med Trop."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.019_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1586\/14760584.2016.1157478","article-title":"Delivery systems for Leishmania vaccine development","volume":"15","author":"Gholami","year":"2016","journal-title":"Expert Rev Vaccines."},{"issue":"11","key":"10.1016\/j.cyto.2018.08.019_b0080","doi-asserted-by":"crossref","first-page":"e0005951","DOI":"10.1371\/journal.pntd.0005951","article-title":"Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis","volume":"11","author":"Cec\u00edlio","year":"2017","journal-title":"PLoS Negl. Trop Dis."},{"issue":"13","key":"10.1016\/j.cyto.2018.08.019_b0085","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.vaccine.2005.11.058","article-title":"Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis","volume":"24","author":"Tewary","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1674-8301(12)60002-5","article-title":"Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops)","volume":"26","author":"Mutiso","year":"2012","journal-title":"J. Biomed. Res."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0095","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly(D, L-lactide-co-glycolide) nanoparticles loaded with soluble <i>Leishmania<\/i> antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"23","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.019_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-7-3","article-title":"Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis","volume":"2","author":"Ramirez","year":"2014","journal-title":"Parasit. Vectors"},{"issue":"8","key":"10.1016\/j.cyto.2018.08.019_b0105","doi-asserted-by":"crossref","first-page":"e0161169","DOI":"10.1371\/journal.pone.0161169","article-title":"Impact of LbSapSal vaccine in canine immunological and parasitological features before and after Leishmania chagasi-challenge","volume":"11","author":"Resende","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0110","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/17425247.2013.838216","article-title":"Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos","volume":"10","author":"Asthana","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.cyto.2018.08.019_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","article-title":"Liposomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective Immunity against visceral leishmaniasis","volume":"30","author":"Sabur","year":"2018","journal-title":"Front. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.cyto.2018.08.019_b0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2051013617741578","article-title":"Liposomal adjuvant development for leishmaniasis vaccines","volume":"5","author":"Askarizadeh","year":"2017","journal-title":"Ther. Adv. Vaccines"},{"issue":"2","key":"10.1016\/j.cyto.2018.08.019_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exppara.2006.07.002","article-title":"Leishmania major: immune response in BALB\/c mice immunized with stress-inducible protein 1 encapsulated in liposomes","volume":"115","author":"Badiee","year":"2007","journal-title":"Exp Parasitol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parint.2014.10.003","article-title":"Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis","volume":"64","author":"Thakur","year":"2015","journal-title":"Parasitol. Int."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/IAI.00611-07","article-title":"gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with Leishmania donovani","volume":"76","author":"Bhowmick","year":"2008","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0140","doi-asserted-by":"crossref","first-page":"e1429","DOI":"10.1371\/journal.pntd.0001429","article-title":"Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection","volume":"5","author":"Mazumder","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2018.08.019_b0145","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2018.08.019_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Current Opin. Microbiol."},{"key":"10.1016\/j.cyto.2018.08.019_b0155","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"issue":"1\u20133","key":"10.1016\/j.cyto.2018.08.019_b0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0009-3084(93)90071-A","article-title":"Liposomes: the Babraham connection","volume":"64","author":"Bangham","year":"1993","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.cyto.2018.08.019_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"Jesus-Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cyto.2018.08.019_b0170","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4\u00b1 and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cyto.2018.08.019_b0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2018.08.019_b0180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"Bhaumik","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vaccine.2009.09.114","article-title":"Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis","volume":"28","author":"Mizbani","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","article-title":"Prophylactic properties of a leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis","volume":"37","author":"Lage","year":"2015","journal-title":"Parasite Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0195","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0200","first-page":"99","article-title":"Vaccine development against Leishmania donovani","volume":"15","author":"Das","year":"2012","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.019_b0205","doi-asserted-by":"crossref","first-page":"e40745","DOI":"10.1371\/journal.pone.0040745","article-title":"Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A","volume":"7","author":"Vitoriano-Souza","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.08.019_b0210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopha.2016.11.087","article-title":"Adjuvant effect of Asparagus racemosus Willd. derived saponins in antibody production, allergic response and pro-inflammatory cytokine modulation","volume":"86","author":"Tiwari","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2018.08.019_b0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exppara.2014.08.016","article-title":"Immunoliposomes containing soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis","volume":"146","author":"Eskandari","year":"2014","journal-title":"Exp. Parasitol."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.019_b0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/17425247.5.7.789","article-title":"Recent developments in leishmaniasis vaccine delivery systems","volume":"5","author":"Bhowmick","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.019_b0225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2012.11.068","article-title":"Micro\/nanoparticle adjuvants for antileishmanial vaccines: present and future trends","volume":"31","author":"Badiee","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.cyto.2018.08.019_b0230","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2018.08.019_b0235","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.019_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2011.558081","article-title":"Liposomal vaccine delivery systems","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.019_b0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.exppara.2012.09.001","article-title":"The role of liposome size on the type of immune response induced in BALB\/c mice against leishmaniasis: rgp63 as a model antigen","volume":"132","author":"Badiee","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cyto.2018.08.019_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2016.07.011","article-title":"Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasis","volume":"309","author":"Sabur","year":"2016","journal-title":"Cell Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.019_b0255","doi-asserted-by":"crossref","first-page":"e3391","DOI":"10.1371\/journal.pntd.0003391","article-title":"DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant","volume":"8","author":"Bayih","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0260","doi-asserted-by":"crossref","first-page":"e0005374","DOI":"10.1371\/journal.pntd.0005374","article-title":"Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis","volume":"11","author":"Asojo","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010129","article-title":"Small Myristoylated protein-3, identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral leishmaniasis","volume":"19","author":"Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cyto.2018.08.019_b0270","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccineagainst visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.cyto.2018.08.019_b0275","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4\u00b1 T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.019_b0280","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.019_b0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0290","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira","year":"2012","journal-title":"Parasitol. Res."},{"issue":"42","key":"10.1016\/j.cyto.2018.08.019_b0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB\/c mouse versus Syrian hamster model","volume":"23","author":"Nieto","year":"2011","journal-title":"Vet. Res."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0300","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.exppara.2006.09.013","article-title":"Leishmania infantum: mixed T-helper-1\/T-helper-2 immune response in experimentally infected BALB\/c mice","volume":"115","author":"Rol\u00e3o","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"11","key":"10.1016\/j.cyto.2018.08.019_b0305","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00962-17","article-title":"Mixed formulation of conventional and pegylated meglumine antimoniate-containing liposomes reduces inflammatory process and parasite burden in Leishmania infantum-infected BALB\/c mice","volume":"61","author":"Reis","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.019_b0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exppara.2008.09.019","article-title":"Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis","volume":"121","author":"Bhardwaj","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.019_b0315","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2011.07.001","article-title":"Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB\/c mice: the contribution of toll-like receptor agonists as adjuvant","volume":"129","author":"Daifalla","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cyto.2018.08.019_b0320","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2015.11.006","article-title":"A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis","volume":"154","author":"Martins","year":"2016","journal-title":"Acta Trop."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T07:40:22Z","timestamp":1549957222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618303557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":64,"alternative-id":["S1043466618303557"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.019","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}